Cargando…
Chemistry of Therapeutic Oligonucleotides That Drives Interactions with Biomolecules
Oligonucleotide therapeutics that can modulate gene expression have been gradually developed for clinical applications over several decades. However, rapid advances have been made in recent years. Artificial nucleic acid technology has overcome many challenges, such as (1) poor target affinity and s...
Autores principales: | Terada, Chisato, Kawamoto, Seiya, Yamayoshi, Asako, Yamamoto, Tsuyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781680/ https://www.ncbi.nlm.nih.gov/pubmed/36559141 http://dx.doi.org/10.3390/pharmaceutics14122647 |
Ejemplares similares
-
Dynamic and static control of the off-target interactions of antisense oligonucleotides using toehold chemistry
por: Terada, Chisato, et al.
Publicado: (2023) -
Highly Potent GalNAc-Conjugated Tiny LNA Anti-miRNA-122 Antisense Oligonucleotides
por: Yamamoto, Tsuyoshi, et al.
Publicado: (2021) -
Recent Advancements in Development and Therapeutic Applications of Genome-Targeting Triplex-Forming Oligonucleotides and Peptide Nucleic Acids
por: Mikame, Yu, et al.
Publicado: (2023) -
Drug discovery and development scheme for liver-targeting bridged nucleic acid antisense oligonucleotides
por: Wada, Fumito, et al.
Publicado: (2021) -
Understanding In Vivo Fate of Nucleic Acid and Gene Medicines for the Rational Design of Drugs
por: Fumoto, Shintaro, et al.
Publicado: (2021)